A composition comprising n-acetylcysteine and / or microencapsulated gastroprotected lysozyme in combination with probiotic bacteria capable of restoring the barrier effect of the stomach itself which is lost during the pharmacological treatment of gastric hyperacidity.
"composition comprising microencapsulated gastroprotected n-acetylcysteine and / or gastroprotected lysozyme in combination with probiotic bacteria capable of restoring the barrier effect of the stomach itself that is lost during the pharmacological treatment of gastric hyperacidity". The present invention relates to a composition comprising n-acetylcysteine and / or lysozyme； or n-acetylcysteine and microencapsulated gastroprotected lysozyme with probiotic bacteria for use in the pharmacological treatment of gastric hyperacidity. said composition is capable of restoring the barrier effect of the stomach itself, which is lost during pharmacological treatment of gastric hyperacidity, and of minimizing side effects due to said pharmacological treatment.resumo patente de invenção: "composição compreendendo n-acetilcisteína e/ou lisozima gastroprotegida microencapsulada em associação com bactérias probióticas capazes de restaurar o efeito de barreira do próprio estômago que é perdido durante o tratamento farmacológico de hiperacidez gástrica". a presente invenção refere-se a uma composição compreendendo n-acetilcisteína e/ou lisozima； ou n-acetilcisteína e lisozima gastroprotegida microencapsulada com bactérias probióticas para uso no tratamento farmacológico de hiperacidez gástrica. a dita composição é capaz de restaurar o efeito de barreira do próprio estômago, que é perdido durante o tratamento farmacológico de hiperacidez gástrica, e de minimizar os efeitos secundários devido ao dito tratamento farmacológico.
